As part of the weekly research here at The Acquirer’s Multiple we’re always interested in superinvestors who hold the same stocks that appear in our Acquirer’s Multiple Stock Screeners, based on their latest 13F’s. Investors such as Warren Buffett, Joel Greenblatt, Carl Icahn, Jim Simons, Prem Watsa, Jeremy Grantham, Seth Klarman, Ray Dalio, and Howard Marks.
While doing this research we’ve also uncovered a number of stocks that superinvestors have sold, or reduced in their portfolios, according to their latest 13f’s. So we’re now providing a new weekly feature article called ‘One Stock Superinvestors Are Selling‘. This week we’ll take a look at:
Pfizer Inc. (NYSE: PFE)
Pfizer is one of the world’s largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales.
A quick look at the price chart below for Pfizer Inc shows us that the stock is up 2.65% in the past twelve months.
Superinvestors who sold, or reduced Pfizer Inc stock in their portfolios include:
(Superinvestor – remaining shares)
Cliff Asness – 9,944,084 shares
Israel Englander – 3,019,616 shares
Ken Fisher – 2,452,376 shares
Rich Pzena – 2,425,518 shares
Charles Brandes – 2,033,999 shares
Jim O’Shaughnessy – 1,265,439 shares
Ken Griffin – 1,173,522 shares
Joel Greenblatt – 931,357 shares
Jeremy Grantham – 183,185 shares
Murray Stahl – 61,482 shares
Ray Dalio – Sold Out
Steve Cohen – Sold Out
Jim Simons – Sold Out
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: